User fee - PDFSEARCH.IO - Document Search Engine

User fee
Results: 1551

#	Item
581	1 DEPARTMENT OF HEALTH AND HUMAN SERVICESPRIVATE Add to Reading List Source URL: www.fda.gov Language: English - Date: 2002-09-18 17:34:53 Pharmacology Health Pharmaceuticals policy Pharmaceutical industry Drug safety New Drug Application Prescription Drug User Fee Act Pharmacovigilance Rosiglitazone Pharmaceutical sciences Food and Drug Administration Medicine
582	1200 G Street NW, Suite 400 Washington, DC 20005–3814 Tel: [removed]Fax: [removed]www.AdvaMed.org Add to Reading List Source URL: www.fda.gov Language: English - Date: 2005-01-05 16:26:05 Pharmaceuticals policy Technology Food law Prescription Drug User Fee Act Federal Food Drug and Cosmetic Act Premarket approval Medical device Abbreviated New Drug Application New Drug Application Food and Drug Administration Medicine Health
583	SOPP[removed]: Procedures for Resubmissions of an Application or Supplement Version # 4 Effective Date: October 1, 2012 I. Purpose This Standard Operating Policy and Procedure (SOPP) describes the policies and procedures f Add to Reading List Source URL: www.fda.gov Language: English Clinical research Pharmacology Pharmaceuticals policy Prescription Drug User Fee Act Drug safety New Drug Application Biosimilar Biologic Email Food and Drug Administration Medicine Pharmaceutical sciences
584	1 DEPARTMENT OF HEALTH AND HUMAN SERVICES FOOD AND DRUG ADMINISTRATION PRESCRIPTION DRUG USER FEE ACT (PDUFA) FDA AND STAKEHOLDERS PUBLIC MEETING Add to Reading List Source URL: www.fda.gov Language: English - Date: 2005-12-29 12:36:02 Clinical research Prescription Drug User Fee Act Eschenbach Food and Drug Administration Steven K. Galson Raymond L. Woosley Health Pharmaceutical sciences Andrew von Eschenbach
585	December 14, 2005 Reference No.: FDAA05019 Dockets Management Branch, HFA-305 Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-01-05 12:40:50 Pharmaceutical sciences Prescription Drug User Fee Act FDA Special Protocol Assessment New Drug Application Center for Biologics Evaluation and Research Plasmapheresis Food and Drug Administration Medicine Health
586	BIOTECHNOLOGY .__l___-l__INDUSTRY ._.____---ORGANIZATION .-..... Add to Reading List Source URL: www.fda.gov Language: English - Date: 2004-11-12 10:50:34 Pharmacology Pharmaceuticals policy Therapeutics United States Public Health Service Biotechnology Prescription Drug User Fee Act Pharmaceutical sciences Food and Drug Administration Clinical research
587	Statement of Sidney M. Wolfe, MD and Larry D. Sasich, Pharm.D., Public Citizen Health Research Group FDA Hearing on Risk Management of Prescription Drugs (docket number 02N-0115) Add to Reading List Source URL: www.fda.gov Language: English - Date: 2002-11-06 16:09:27 Health Food and Drug Administration Pharmaceuticals policy Pharmacy Pharmaceutical industry Boxed warning Adverse effect Prescription Drug User Fee Act Center for Drug Evaluation and Research Pharmaceutical sciences Pharmacology Medicine
588	Alan Goldhammer, PhD Associate Vice President, US Regulatory Affairs Add to Reading List Source URL: www.fda.gov Language: English - Date: 2004-11-05 15:26:13 Health Medicine Food law Pharmacology Prescription Drug User Fee Act New Drug Application Federal Food Drug and Cosmetic Act Pharmaceutical industry Food and Drug Administration Pharmaceuticals policy Pharmaceutical sciences
589	Wyeth Wyeth Pharmaceuticals Add to Reading List Source URL: www.fda.gov Language: English - Date: 2003-10-27 08:41:11 Food and Drug Administration Health Prescription Drug User Fee Act Drug safety Wyeth Over-the-counter drug Pharmaceuticals policy Pharmacology Pharmaceutical sciences
590	Alan Goldhammer, PhD Associate Vice President, US Regulatory Affairs Add to Reading List Source URL: www.fda.gov Language: English - Date: 2003-10-27 08:41:10 Pharmacology Drug safety Health Clinical research Prescription Drug User Fee Act Pharmaceutical industry New Drug Application Food and Drug Administration Pharmaceutical sciences Pharmaceuticals policy

UPDATE